4Filing Date: Sep 10, 2026
Vertex (VRTX)
Statement of Changes in Beneficial Ownership
View SEC Filing
ACC: 0000875320-26-000272
Total Value$0
Trades1
Insiders1
Transaction Details
van Grunsven Jasper
EVP, CP and NPPO·Direct
Grant · Acquire
Common Stock
Shares+8.68K
Price$0.00
Total Value$0
Shares Owned After8.68K
Transaction DateSep 8, 2026
Footnotes ▸
Restricted stock unit award that vests in installments beginning on 09/08/2027.
Post-Transaction Holdings
van Grunsven Jasper · EVP, CP and NPPO
| Security | Shares | Change |
|---|---|---|
| Common Stock | 8.68K | +8.68K |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-09-08
10b5-1 Pre-arranged Plan: No
--- Issuer ---
Name: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
--- Reporting Owner ---
Name: van Grunsven Jasper
CIK: 0002154061
Role: Officer (EVP, CP and NPPO)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-09-08 | Code: A (Grant or award)
Shares: +8,682 | Price: $0.00
Shares Owned After: 8,682 | Ownership: D (Direct)
Footnotes:
[F1] Restricted stock unit award that vests in installments beginning on 09/08/2027.
--- Footnotes (Complete Index) ---
F1: Restricted stock unit award that vests in installments beginning on 09/08/2027.
--- Signature ---
/s/ /s/ Christiana Stevenson, Attorney-in-Fact (2026-09-10)